Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Natural killer (NK) cells attack tumor and infected cells, but the receptors and ligands that stimulate them are poorly understood. Here we report the expression cloning of two murine ligands for the lectin-like receptor NKG2D. The two ligands, H-60 and Rae1 beta, are distant relatives of major histocompatibility complex class I molecules. NKG2D ligands are not expressed by most normal cells but are up-regulated on numerous tumor cells. We show that mouse NKG2D is expressed by NK cells, activated CD8+ T cells and activated macrophages. Expression of either NKG2D ligand by target cells triggers NK cell cytotoxicity and interferon-gamma secretion by NK cells, as well as nitric oxide release and tumor necrosis factor alpha transcription by macrophages. Thus, through their interaction with NKG2D, H-60 and Rae1 beta are newly identified potent stimulators of innate immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies from our laboratory demonstrated that transplanted tumor cells expressing NKG2D ligands are rejected by NK cells and, in some cases, T cells (Diefenbach et al., 2000, 2001, 2003)”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Diefenbach et al., 2000
Citations
Cites
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,146 · cited 1×
“The extrachromosomal DNA was extracted from the sorted cells as describe”
MethodPhenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“The recombinant protein was purified from inclusion bodies and refolded in vitro as describe”
MethodActivation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999 · cited 1×
“The MHC-encoded proteins MICA and the closely related MICB are distantly related to MHC class I protein”
BackgroundBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902 · cited 2×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodIn search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialProduction of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,266
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648 · cited 4×
“(a) Stably transfected CHO cells expressing high levels of NKG2D-DAP10 (filled histograms), NKG2A-CD94 (2) or NKG2C-CD94 (3) as well as untransfected control cells (1) were stained with the absorbed antiserum against mNKG2D.”
MethodInfluentialAn Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039 · cited 1×
“Recent evidence indicates that human NKG2D forms a homodimer that associates with the signaling subunit DAP10 on the surface of NK cells and CD8 + T cell”
BackgroundBroad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017 · cited 1×
“MICA and MICB are normally expressed on a subset of intestinal epithelial cells, but their expression is up-regulated by cellular stres”
Background
Research works printed but not linked: 2
- Cosman, D. et al. The human cytomegalovirus (HCMV) glycoprotein, UL16, binds to the MHC class I-related protein, MICB/PERB11, and to two novel, MHC class I-related molecules, ULBP1 and ULBP2. FASEB J. 14, A1018 (2000).
- Chalupny, J. et al. Soluble forms of the novel MHC class I–related molecules, ULBP1 and ULBP2, bind to, and functionally activate NK cells. FASEB J. 14, A1018 (2000).
Cited by
Items 601–700 of 875
Joo, W. S., Jeong, J. H., Nam, K., Blevins, K. S., Salama, M. E., & Kim, S. W. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.008 · Cited by 12
“Expression of NKG2D can be observed in activated or memory CD8+ T-cells but not in naïve CD8+ nor CD4+ T-cells [9].”
InfluentialImmunopathology and Immunomodulation
Metodiev, K. (2015) · InTech eBooks · doi:10.5772/59217 · Cited by 15
Lin, F., Dai, C., Ge, X., Tang, W., Lin, Y., Wang, Y., & Li, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.104 · Cited by 12
Prinz, D., Klein, K., List, J., Knab, V. M., Menzl, I., Leidenfrost, N., Heller, G., Polić, B., Putz, E. M., Witalisz‐Siepracka, A., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.201948222 · Cited by 15
Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy
Niu, Y.-X., Xu, Z., Yu, L., Lu, Y., Wang, Y., Wu, C., Hou, Y.-B., Li, J., Huang, S., Song, X., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108783 · Cited by 12
Buhtoiarov, I. N., Rakhmilevich, A. L., Lanier, L. L., Ranheim, E. A., & Sondel, P. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800443 · Cited by 12
“Although the expression of NKG2D and its potential role in M activation and M -mediated killing has been controversial (17, 35), our data document up-regulation of cell surface NKG2D on M when cultured along with L5178Y cells and LPS.”
BackgroundResultMucosal T lymphocytes—peacekeepers and warriors
Cheroutre, H., & Kronenberg, M. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-005-0205-7 · Cited by 12
“Mice do not express structural homologs of MICA and MICB, although they do have NKG2D receptors and class I-like molecules that can bind to these [96, 97].”
BackgroundFujita, H., Hatanaka, Y., Sutoh, Y., Suzuki, Y., Oba, K., Hatanaka, K. C., Mitsuhashi, T., Otsuka, N., Fugo, K., Kasahara, M., et al. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414563800 · Cited by 13
“The NKG2D receptor ligands are distant homologs of major histocompatibility complex (MHC) class I molecules (Bauer et al. 1999; Cerwenka et al. 2000; Diefenbach et al. 2000), and include two families in humans: the MHC class I-chain-related proteins (MIC) A and B (Bauer et al.1999), and the…”
BackgroundSavithri, B., & Khar, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200535350 · Cited by 13
Teng, M. W. L., Kershaw, M. H., Hayakawa, Y., Cerruti, L., Jane, S. M., Darcy, P. K., & Smyth, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505331200 · Cited by 12
The dynamics of natural killer cell tolerance
Johansson, M. H., & Höglund, P. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.013 · Cited by 14
Johansson, M. H., & Höglund, P. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01363.x · Cited by 12
Steiger, S., Kuhn, S. P., Ronchese, F., & Harper, J. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401755 · Cited by 14
“In particular, increased macrophage NKG2D expression has been linked to regulation of granzyme B/perforin-dependent killing functions (26, 27), similar to that also reported for NK receptor– expressing DCs (28).”
ResultFlip‐flops of natural killer cells in autoimmune diseases versus cancers: Immunologic axis
Shahrabi, S., Zayeri, Z. D., Ansari, N., Hadad, E. H., & Rajaei, E. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28421 · Cited by 11
Inflammatory Cytokine–Mediated Evasion of Virus-Induced Tumors from NK Cell Control
Mishra, R., Polić, B., Welsh, R. M., & Szomolanyi‐Tsuda, E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203328 · Cited by 14
“Many primary human cancers, mouse tumors, and established tumor cell lines express NKG2D ligands, and the recognition of these ligands by NKG2D can tip the balance and lead to the activation of NK cells and NK cell–mediated cytolysis of the cells expressing the stress ligands (20).”
BackgroundLi, J. S. Y., Rabinovich, B. A., Hurren, R., Cosman, D. J., & Miller, R. G. (2005) · European Journal of Immunology · doi:10.1002/eji.200425621 · Cited by 11
Cellular Therapy of Cancer with Natural Killer Cells: Will It Ever Work?
Klingemann, H.-G. (2001) · Stem Cells and Development · doi:10.1089/152581601750098174 · Cited by 11
“Such inhibition occurs when killer cell inhibitory receptors (KIR) on the surface of NK cells react with class I MHC structures on target cells (8).”
Rojas, J. M., Spada, R., Sanz-Ortega, L., Morillas, L., Mejías, R., Mulens‐Arias, V., Pérez-Yagüe, S., & Barber, D. F. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a1215-541rr · Cited by 11
“4). p85b deficiency increased IFN-g production and degranulation after activation by NKG2D Because DAP10 has a YINM motif that recruits the PI3K p85 subunit, we focused our analysis on the NKG2D activating receptor to characterize the functional phenotype of p85b-deficient NK cells.”
BackgroundMethodInfluentialWu, P. (2005) · Frontiers in bioscience · doi:10.2741/1770 · Cited by 12
“3138 the expression of NKG2D (29, 32, 34, 92), mechanisms that control the expression of NKG2D receptor were still illusive and the possible regulatory factors needed to be clearly defined in details.”
BackgroundJames, L. C. (2005) · Frontiers in bioscience · doi:10.2741/1628 · Cited by 10
Pinto, A. K., Jamieson, A. M., Raulet, D. H., & Hill, A. B. (2007) · Journal of Virology · doi:10.1128/jvi.01328-07 · Cited by 10
“ligands, the RAE-1 family of molecules, H-60, and MULT-1 (5, 8, 9).”
MethodSelf-citationLilue, J., Doran, A., Fiddes, I. T., Abrudan, M. I., Armstrong, J. C., Bennett, R., Chow, W., Collins, J., Collins, S. C., Czechanski, A., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/235838 · Cited by 10
Gao, Y., Zhou, R., Wang, Q., Qi, S., Lv, Y., Liu, S., Shen, J., & Yu, G. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.109521 · Cited by 9
Self-citationMay, L., Hu, B., Jerajani, P., Jagdeesh, A., Alhawiti, O., Cai, L., Semenova, N., Guo, C., Isbell, M., Deng, X., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0585 · Cited by 10
“Acquired” NKG2D Ligand Stimulates NK Cell–mediated Tumor Immunosurveillance
Wang, D., Gu, X., Liu, X., Liu, X., Wang, B., Lao, F., & Fang, M. (2019) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000276 · Cited by 9
Li, X., Guo, X., Huang, J., Lin, Q., Qin, B., Jiang, M., Shan, X., Luo, Z., Zhang, J., Shi, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.032 · Cited by 9
Kohlhapp, F. J., O’Sullivan, J. A., Moore, T. V., Zloza, A., & Guevara-Patino, J. A. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2022.12.013 · Cited by 11
The dysfunction of natural killer cells is essential for the development of type 1 diabetes
Sabetkam, S., Kalarestaghi, H., Mazloumi, Z., Asl, K. D., Norouzi, N., & Rafat, A. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154556 · Cited by 10
Fodil-Cornu, N., Loredo‐Osti, J. C., & Vidal, S. M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001368 · Cited by 9
Hu, J., Vien, L., Xia, X., Bover, L. C., & Li, S. (2014) · Biological Procedures Online · doi:10.1186/1480-9222-16-3 · Cited by 9
“Some groups have reported that live mammalian cells that express certain proteins on their surfaces could be used to immunize animals to generate mAbs [4,5].”
BackgroundFlanagan, M. L., Khawli, L. A., Hu, P., & Epstein, A. L. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000199194.90222.1a · Cited by 10
“Tumor cells engineered to express H60 were rejected in studies conducted by other laboratories.(5,37) In the present study, we sought to demonstrate whether delivery of the extracellular portion of H60 to experimental tumors could result in antitumor effects.”
BackgroundDevelopment of a murine model of lymph node metastases suitable for immunotoxicity studies
Egenolf, D., Rafferty, P., Brosnan, K., Walker, M., Jordan, J. L., Makropoulos, D., Kavalkovich, K. W., Watson, S., Johns, L., Volk, A. L., et al. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.12.001 · Cited by 9
A dual function of NKG 2 D ligands in NK ‐cell activation
Cheney, E. E., Wise, E. L., Bui, J. D., Schreiber, R. D., Carayannopoulos, L. N., Spitzer, D., Zafirova, B., Polić, B., Shaw, A. S., & Markiewicz, M. A. (2012) · European Journal of Immunology · doi:10.1002/eji.201141849 · Cited by 9
“In addition, NKG2D can costimulate CD8+ T cell responses [14–19], a function that requires MHC class I expression.”
BackgroundMicrobiome and Gut Immunity: Innate Immune Cells
Strowig, T., Thiemann, S., & Diefenbach, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_8 · Cited by 11
Self-citationDevelopment, Function, and Specificity of Intestinal Intraepithelial Lymphocytes
Kronenberg, M., & Cheroutre, H. (2005) · Elsevier eBooks · doi:10.1016/b978-012491543-5/50034-6 · Cited by 9
Kärre, K. (2002) · Nature Immunology · doi:10.1038/ni0602-505 · Cited by 9
Ide, A., Babu, S. R., Robles, D. T., Wang, T., Erlich, H. A., Bugawan, T. L., Rewers, M., Fain, P. R., & Eisenbarth, G. S. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-4826-3 · Cited by 9
Malarkannan, S., Regunathan, J., & Timler, A. M. (2005) · Clinical and Applied Immunology Reviews · doi:10.1016/j.cair.2004.09.002 · Cited by 9
Zhang, B., Wei, H., Zheng, X., Zhang, J., Sun, R., & Tian, Z. (2004) · Peptides · doi:10.1016/j.peptides.2004.10.008 · Cited by 9
Clinical Studies on Cytokine-Induced Killer Cells: Lessons from Lymphoma Trials
Zhang, Y., Sharma, A., Weiher, H., Schmid, M. C., Kristiansen, G., & Schmidt‐Wolf, I. G. H. (2021) · Cancers · doi:10.3390/cancers13236007 · Cited by 8
“of the UL16-binding protein family (ULBP1-4) [24].”
Yang, Y., Jiang, Y., Xie, B., Shi, S., Pi, F., Chen, M., Sang, C., Xu, L., & Chen, T. (2023) · Biomaterials Science · doi:10.1039/d2bm01752k · Cited by 9
Characterization of 5′ promoter and exon 1–3 polymorphism of the RAET1E gene
Cox, S. T., Pearson, H. M., Briviesca, R. L., Pesoa, S., Vullo, C., Madrigal, J. A., & Saudemont, A. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.10.017 · Cited by 8
Wilk, E. (2002) · Immunobiology · doi:10.1078/0171-2985-00130 · Cited by 8
Benish, M., Melamed, R., Rosenne, E., Neeman, E., Sorski, L., Levi, B. Z., Shaashua, L., Matzner, P., & Ben‐Eliyahu, S. (2013) · Immunologic Research · doi:10.1007/s12026-013-8435-6 · Cited by 9
“YAC-1 cells express NKG2D ligands constitutively [16, 17], as opposed to B16 cells [17], and are thus prone to NKG2D-mediated cytotoxicity.”
BackgroundPrinciples of Cancer Immunobiology and Immunotherapy of Solid Tumors
Konsoulova, A. (2015) · InTech eBooks · doi:10.5772/61211 · Cited by 10
“The expression of those ligands is induced on the surface of the stressed transformed tumor cells [3,4].”
BackgroundDevelopment and Function of Natural Killer Cells and Its Importance in Cancer Immunotherapy
Paul, S., & Lal, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809819-6.00009-5 · Cited by 11
Dulaimi, D. A., Klibi, J., Pimentel, V. O., Parietti, V., Allez, M., Toubert, A., & Benlagha, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01052 · Cited by 8
Large scale ex vivo expansion of clinical‑grade effector cells for adoptive immunotherapy
Yu, H., Chen, W., Li, C., Lin, D., Liu, J., Yang, Z., Yang, J., Sun, Y., & Ma, D. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5228 · Cited by 8
“In vitro studies have demonstrated that binding of NKG2D and its ligands provides signals for NK cell activation and co-stimulatory signals for T-cells (35,37,38).”
Larson, J. H., Rebeiz, M., Stiening, C. M., Windish, R., Beever, J. E., & Lewin, H. A. (2003) · Immunogenetics · doi:10.1007/s00251-003-0551-3 · Cited by 8
Role of CD4 T lymphocytes in antitumor immunity
Rajnavölgyi, É., & Lányi, Á. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87209-3 · Cited by 11
Peripheral blood gamma-delta T cells in advanced-stage cancer patients
Bilgi, O., Karagöz, B., Türken, O., Kandemir, E. G., Öztürk, A., Gümüş, M., & Yaylacı, M. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0032-z · Cited by 8
The Role of Natural Killer Cells in Innate Immunity to Infection
Yokoyama, W. M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-320-0_18 · Cited by 10
Role of CD4+ T lymphocytes in antitumor immunity
Rajnavölgyi, É., & Lányi, Á. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)87298-6 · Cited by 8
The inhibitory NKR-P1B receptor regulates NK cell-mediated mammary tumor immunosurveillance in mice
Olabi, R. A., Hendy, A. E. A., Alkassab, M. B., Alnajm, K., Elias, M., Ibrahim, M., Carlyle, J. R., Makrigiannis, A. P., & Rahim, M. M. A. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2168233 · Cited by 7
Patil, S., & Schwarer, T. (2009) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.02024.x · Cited by 8
Constitutive expression of ULBP-4 on monocytes regulates NK cell NKG2D expression.
Sharma, N., & Markiewicz, M. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018025742 · Cited by 7
“ULBP-4 expression was also reduced on monocytes after coculture with NK cells, whereas soluble ULBP-4 levels were unchanged (supplemental Figure 1C-D), indicating ULBP-4 may be internalized along with NKG2D.”
BackgroundCampos‐Silva, C., López-Borrego, S., Felgueres, M. J., Esteso, G., & Valés‐Gómez, M. (2022) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2022045263 · Cited by 8
Lopez, K., Spence, J. P., Li, W., Zhang, W., Wei, B., Cross-Najafi, A. A., Butler, J. R., Cooper, D. K. C., Ekser, B., & Li, P. (2023) · Cells · doi:10.3390/cells12222587 · Cited by 7
“NKG2D ligands include ULBPs and MHC class I chain-related protein (MIC) A and B in humans [18,19], as well as Rae-1 and H-60 in mice [20,21].”
BackgroundRole of natural killer cells in antitumor resistance
Kaneno, R. (2005) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 7
In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors
Kotturi, H. S. R., Li, J., Branham-O’Connor, M., Yu, X., Wagner, T. E., & Wei, Y. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.69 · Cited by 7
Smits, N. C., Coupet, T. A., Godbersen, C., & Sentman, C. L. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1195364 · Cited by 10
Trembath, A. P., Sharma, N., Raju, S., Polić, B., & Markiewicz, M. A. (2017) · ImmunoHorizons · doi:10.4049/immunohorizons.1700011 · Cited by 6
Lis, N., Hein, Z., Ghanwat, S., Ramnarayan, V. R., Chambers, B. J., & Springer, S. (2021) · Journal of Cell Science · doi:10.1242/jcs.257428 · Cited by 7
NF-κB p50/p65 Affects the Frequency of Ly49 Gene Expression by NK Cells
Pascal, V., Nathan, N. R., Claudio, E., Siebenlist, U. K., & Anderson, S. K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1751 · Cited by 10
Rubin, B., Riond, J., Courtiade, L., Roullet, N., & Gairin, J.-E. (2008) · PubMed Central · Cited by 7
NKG2D Ligand Expression Induced by Oxidative Stress Mitigates Cutaneous Ischemia–Reperfusion Injury
Makita, K., Otsuka, N., Tomaru, U., Taniguchi, K., & Kasahara, M. (2023) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554221147582 · Cited by 6
THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling
Deborah, E. A., Nabekura, T., Shibuya, K., & Shibuya, A. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300771 · Cited by 6
Cytokine induced killer cell immunotherapy in cancer treatment: from bench to bedside
Arafar, A. (2014) · Biomedical Research and Therapy · doi:10.7603/s40730-014-0012-7 · Cited by 6
“Ligands for NKG2D were restrictedly expressed in malignant cells (Diefenbach et al., 2000; Jamieson et al., 2002).”
BackgroundChoi, E. Y., Choi, K., Nam, G., Kim, W., & Chung, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01163 · Cited by 6
“After paralog genes (H60b and H60c) encoding additional NKG2D ligands were identified (28), the original H60 was renamed H60a.”
BackgroundInfluentialEffect of proinflammatory cytokines on PIGA− hematopoiesis
Kulkarni, S., & Bessler, M. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00189-9 · Cited by 6
Forman, J., & Lindahl, K. F. (2002) · Current Protocols in Immunology · doi:10.1002/0471142735.ima01ms49 · Cited by 6
Immune cell phenotype and function patterns across the life course in individuals from rural Uganda
Nalwoga, A., Nakibuule, M., Roshan, R., Mbonye, M. K., Miley, W., Whitby, D., Newton, R., Rochford, R. A., & Cose, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1356635 · Cited by 5
Lu, S., Yin, Z., Wu, L., Sun, Y., Chen, J., Wu, L. M. N., Oblinger, J. L., Blake, D. C., Xiu, B., Landegger, L. D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68865-8 · Cited by 8
“In mice, NKG2D binds to its ligands RAE-1 and H60A 21,22 . α VEGF treatment also signi fi cantly increased the expression of Rae-1 and H60a , but did not affect the expression of the inhibitory receptor Nkg2a (Fig.”
Fišerová, A., Richter, J., Čapková, K., Bieblová, J., Mikyšková, R., Reiniš, M., & Indrová, M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3561 · Cited by 5
Liver stroma enhances activation of TLR3-triggered NK cells through fibronectin
Xia, S., Guo, Z., Yao, Y., Xu, X., Yi, H., Xia, D., & Cao, X. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.035 · Cited by 5
Stern‐Ginossar, N., & Mandelboim, O. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-370454-2.00011-9 · Cited by 9
Altmeyer, S., Zentek, J., Vahjen, W., & Scharek-Tedin, L. (2017) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2017.03.005 · Cited by 5
MHC class I receptors on natural killer cells: on with the old and in with the new
Khakoo, S. I., & Brooks, C. (2003) · Clinical Science · doi:10.1042/cs20030095 · Cited by 6
NK cell receptors: emerging roles in host defense against infectious agents
Robbins, S. H., & Brossay, L. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00035-7 · Cited by 5
Broad antitumor protection by dendritic cells administered to CD8α knock out mice
Ribas, A., Vo, D. D., Weeks, D. L., Comı́n-Anduix, B., Schumacher, L., Garbán, H., McLean, C., Yang, J.-Q., Dissette, V. B., Peraza, P., et al. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0065-y · Cited by 5
“As previously described [2], the NKG2D antibody blocked the lysis of the allogeneic lymphoma Yac-1 cells, while it had no effect on the lytic activity on B16 (Fig.”
BackgroundBezouška, K. (2004) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc20040535 · Cited by 7
Peinado, C. D., Kang, X., Hardamon, C. R., Arora, S., Mah, S., Zhang, H., Ngolab, J., & Bui, J. D. (2013) · Immunology · doi:10.1111/imm.12080 · Cited by 5
Regulation of natural killer cell function: a role for the NK cell’s own MHC class I molecules
Held, W., Chalifour, A., & Coudert, J. D. (2005) · Medical Microbiology and Immunology · doi:10.1007/s00430-004-0235-0 · Cited by 6
“However, NKG2D ligands can also be induced during the course of normal cellular activation and differentiation [30].”
BackgroundMinor histocompatibility antigens: time for a paradigm shift?
Malarkannan, S. (2005) · Transplantation Reviews · doi:10.1016/j.trre.2005.02.001 · Cited by 5
“Recent studies on mH-Ags are revealing another clinical facet of these proteins [4-6].”
Symmonds, J., Gaufin, T., Xu, C., Raehtz, K. D., Ribeiro, R. M., Pandrea, I., & Apetrei, C. (2024) · Viruses · doi:10.3390/v16060972 · Cited by 5
“Upon stimulation through NKG2D receptor signaling [309] or contact-dependent interactions with mature dendritic cells [310], NKs produce IFN-γ , thus promoting T-cell sensitization to the effects of IL-2 [311], T-helper 1 cell development, and macrophage activation.”
BackgroundIntratumoral T reg cell ablation elicits NK cell–mediated control of CD8 T cell–resistant tumors
Zhang, C., Chien, C., Jurgaitytė, E., Sakiyama, K., Bockman, A., Jo, Y., Lee, S., Silveria, S. L., Andrews, E., Mende, A., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.adx4411 · Cited by 6
Self-citationZou, M., Al‐Yahya, S., Al-Alwan, M. M., BinEssa, H. A., Khabar, K. S. A., Almohanna, F., Assiri, A. M., Altaweel, A., Qattan, A. T., Meyer, B. F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1171816 · Cited by 5
Specialized Antitumor Functions for Skin γδ T Cells
Havran, W. L. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800356 · Cited by 4
“(11) postulated that murine skin tumors will also express NKG2D ligands (25, 26).”
BackgroundRangarajan, S., & Mariuzza, R. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803369-2.00004-8 · Cited by 4
Regulatory NK1.1−CD4+NKG2D+ subset induced by NKG2DL+ cells promotes tumor evasion in mice
Lin, Z., Han, S., Qian, X., Hu, C., Xiao, W., Qian, L., Zhang, Y., Ding, Y., Jia, X., Zhu, G., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2172-6 · Cited by 4
Khetsuphan, T., Chaisri, U., Dechkhajorn, W., Benjathummarak, S., Dekumyoy, P., Ampawong, S., Viriyavejakul, P., & Maneerat, Y. (2020) · Parasitology Research · doi:10.1007/s00436-019-06593-3 · Cited by 4
C-Type Lectins and Their Roles in Disease and Immune Homeostasis
Ebbecke, T., Diersing, C., Lindenwald, D. L., Stegmann, F., & Lepenies, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00063-8 · Cited by 4
Signaling in Natural Immunity: Natural Killer Cells
Arneson, L. N., & Leibson, P. J. (2005) · Neuroimmune biology · doi:10.1016/s1567-7443(05)80014-6 · Cited by 5
Strategies of Natural Killer (NK) Cell Recognition and Their Roles in Tumor Immunosurveillance
Stewart, C. A., & Vivier, É. (2008) · Springer eBooks · doi:10.1007/978-4-431-73884-8_2 · Cited by 7
Yisheng Injection Decreases the Expression of H60 and RAE-1 Genes in Ischemic Mice Liver
Cheng, F., Feng, L., Li, S., Tan, J., Cao, L., He, Y., Ye, Z., & Li, Y. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.06.100 · Cited by 4
Minor histocompatibility antigens: molecular targets for adoptive cellular immunotherapy
Malarkannan, S. (2002) · Current Opinion in Organ Transplantation · doi:10.1097/00075200-200209000-00015 · Cited by 4
Abdulnour‐Nakhoul, S. M., Kolls, J. K., Flemington, E. K., Ungerleider, N., Nakhoul, H. N., Song, K., & Nakhoul, N. L. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00066.2023 · Cited by 3
Lemasson, Q., Akil, H., Feuillard, J., & Vincent‐Fabert, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669964 · Cited by 3
Ngo, H. T., Dang, V. T., Nguyen, N. H.-T., Bui, A. N.-T., & Pham, P. V. (2022) · Cell and Tissue Banking · doi:10.1007/s10561-022-10022-8 · Cited by 4
Rojas‐Domínguez, A., Martínez-Vargas, I. U., & Alvarado, M. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109717 · Cited by 5
Metadata
- Authors
- Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature Immunology
- Published
- 2000-08
- Volume
- 1
- Issue
- 2
- Pages
- 119-126
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1603913234
- Cited by
- 878
- References
- 41
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 17 · 2023: 12 · 2022: 28 · 2021: 17 · 2020: 23 · 2019: 18 · 2018: 29 · 2017: 31 · 2016: 17 · 2015: 23 · 2014: 24 · 2013: 28 · 2012: 38
- FWCI
- 18.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- NKG2D, NKG2D ligands, natural killer cells, macrophages, cancer cells, innate immunity, NK cell cytotoxicity, interferon-gamma, nitric oxide, TNF-α, MHC class I-related molecules, CD8+ T cells, expression cloning
- MeSH terms
- Animals, Chlorocebus aethiops, Cloning, Molecular, Cricetinae, Humans, Killer Cells, Natural, Ligands, Lymphocyte Activation, Macrophage Activation, Membrane Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Receptors, Immunologic, Tumor Cells, Cultured, Minor Histocompatibility Antigens, CHO Cells, Macrophages, Peritoneal, COS Cells, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.